The U.S. Drug Enforcement Agency communicated to an in-house judge on Thursday that a process to reschedule marijuana ...

The ordeal began in 2018 when MMJ Biopharma Cultivation submitted its application for a DEA bulk manufacturing registration (grow pharmaceutical marijuana). The company's objective was clear and ...

WASHINGTON, D.C. / ACCESS Newswire / April 9, 2025 / The United States Drug Enforcement Administration ... delays that have stalled vital medical marijuana research, it's about the integrity ...

The legal status of cannabis and hemp in the United States remains uncertain, which makes the executive branch’s policy ...

"The DEA can't demand compliance from others while ignoring its own obligations." According to 28 U.S.C. § 530B, federal attorneys are required to abide by the ethical rules of the states in ...

Marijuana plants grow at a Minnesota Medical Solutions greenhouse in Otsego, Minn., on May 5, 2015. (Glen Stubbe/Star Tribune via AP, File) WASHINGTON (CN) — Members of Congress on Wednesday once ...

The ordeal began in 2018 when MMJ Biopharma Cultivation submitted its application for a DEA bulk manufacturing registration (grow pharmaceutical marijuana). The company's objective was clear and ...

DEA Marijuana Seven-Year Delay in MMJ Biopharma Cultivation's Application Sparks Calls for DEA Accountability and Reform "This isn't just a case of bureaucratic red tape or administrative lag-this ...